# Pharma Plus -Sales & Profitability-Analysis
## Project Background
Pharma Plus is an European pharmacy chain distributor operating in eight European countries - Germany, France, Italy, Belgiun, Netherland, Spain, Poland and Austria. The company utilizes Excel to record daily transactions, including geographic, pharmacy and products category information.

This report presents a comprehensive analysis of the company dataset to help stakeholder understand sales and profitability, products and categories, pharmacy dynamics  across countries and regions from  2024  to 2025.
### The analysis delivers insights and strategic recommendations across the following key areas:
### Revenue Trend Analysis: 
Year-over-Year performance evaluation covering Revenue, Unit Sold, Profit and Profit Margin with 

a focus on seasonal trends and growth patterns

### Geographic and pharmacy-level performance: 
Regional and store-level analysis highlighting where Pharma Plus is outperforming and where

performance gaps exist across markets.

### Product & Profitability Analysis: 
Detailed product performance assessment to determine which products to sell motre, promote, 

optimize, or discontinue based on revenue, margin, and volume contribution.

An interactive Power BI report can be downloaded [**here**](https://app.powerbi.com/view?r=eyJrIjoiMDgwMjFkNTYtZmIwZS00Y2IzLWI0OTctNzBhMWMyYjVhZjRkIiwidCI6IjQ2NTRiNmYxLTBlNDctNDU3OS1hOGExLTAyZmU5ZDk0M2M3YiIsImMiOjl9)

SQL query used in  cleaning and creating the tables can be found [here](https://github.com/Mercygold101/Pharma-Plus---Sales-Profitability-Analysis/blob/main/Phaemacy%20sales%20analysis.sql)

Targeted SQL queries used in answering variuos business questions can be found [here](https://github.com/Mercygold101/Pharma-Plus---Sales-Profitability-Analysis/blob/main/Phaemacy%20sales%20analysis.sql)

### Data Structure
Pharma Plus database consist of four tables - Sales, Pharmacy, Products & Dates a total row count of 62,140 records.
<img width="1282" height="940" alt="ERD Pharma Plus data" src="https://github.com/user-attachments/assets/0a58a88b-c6fc-47f1-ac08-86c9630588b2" />
### Excecutive Summary
Overview of findings

The company sales revenue incresead with a significant growth of 19% in 2025. Year over Year comparison trends show a positive profitability of +0.07 percentage points in 2025 compared to 2024. This improvement represents meaningful value when applied to overall revenue. Seasonal analysis reveals strong sales momentum from the mid-year through last quarter, with the Average monthly revenue of 
€719,18K in 2025.
![pharma overview1](https://github.com/user-attachments/assets/0ffbf11b-dd69-4b5b-bb1e-0f3de5864ad9)
